Indications
Von Willebrand disease (VWD) Prophylaxis and treatment of haemorrhage or surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital factor-VIII deficiency) Prophylaxis and treatment of bleeding in patients with haemophilia A.
Composition
- Active substance
- human coagulation factor VIII, human von willebrand factor
- International name (INN)
- human coagulation factor VIII / human von willebrand factor
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Voncento
- Active substance
- human coagulation factor VIII, human von willebrand factor
- ATC code
- B02BD06